苏州欧康维视生物科技有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:14
Drug Approvals
Emedastine Difumarate Eye Drops
- Product Name
- 富马酸依美斯汀滴眼液
- Approval Number
- 国药准字H20258020
- Approval Date
- Feb 21, 2025
NMPA
Bromfenac Sodium Eye Drops
- Product Name
- 溴芬酸钠滴眼液
- Approval Number
- 国药准字H20253042
- Approval Date
- Jan 2, 2025
NMPA
Oxybuprocaine Hydrochloride Eye Drops
- Product Name
- 盐酸奥布卡因滴眼液
- Approval Number
- 国药准字H20249589
- Approval Date
- Dec 1, 2024
NMPA
Brimonidine Tartrate Eye Drops
- Product Name
- 酒石酸溴莫尼定滴眼液
- Approval Number
- 国药准字H20249123
- Approval Date
- Oct 22, 2024
NMPA
Cetirizine Hydrochloride Eye Drops
- Product Name
- 盐酸西替利嗪滴眼液
- Approval Number
- 国药准字H20244893
- Approval Date
- Sep 10, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20244235
- Approval Date
- Jun 28, 2024
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found